200 more Olongapo City residents now fully vaccinated against COVID | Inquirer News

200 more Olongapo City residents now fully vaccinated against COVID

COVID-19 vaccination at SMX Convention Center in Olongapo City

Residents of Olongapo City wait for their turn to get vaccinated against COVID-19 during the jab rollout at the SMX Convention Center of SM Olongapo Central. (Photo courtesy of Olongapo City Information Office)

OLONGAPO CITY—About 200 more residents here received their second dose of Coronovac (Sinovac) shots as the City resumed Wednesday its COVID-19 vaccine rollout on Wednesday.

Most of those who returned to the vaccine site at the SMX Convention Center of SM Olongapo Central to complete their jabs were senior citizens and residents with ailments.

Article continues after this advertisement

The city government said no additional supply of vaccines have arrived here yet for those waiting for their first dose.

FEATURED STORIES

Over 19,500 residents in the City have been inoculated against COVID-19, but only close to 5,000 received their second dose. The City has been administering the Sinovac vaccine from China and AstraZeneca from the U.K.

The turnout remained below the target for herd immunity, which is around 140,000 residents.

lzb
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronovac, COVID-19, Olongapo City, Regions, second dose, Sinovac

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.